• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

New Lighthouse Initiative to Provide De-identified Patient Data for VIRUS COVID-19 Registry

Share:

July 15, 2020

Highlights on this story:
  • PointClickCare introduces the Lighthouse initiative, which will provide de‐identified data on COVID‐19 diagnosed patients, including demographics, vitals, medications and health‐related outcomes, in order to better understand health outcomes post‐ICU.
  • Comprehensive data sets are especially critical tools in responding to crises like the current COVID-19 pandemic, and this initiative is one example of PointClickCare’s efforts to arm frontline workers with the tools they need to keep vulnerable populations safe during this time.

PointClickCare, the leading cloud-based software platform for the senior care market has been selected by the Society of Critical Care Medicine (SCCM) to launch the Lighthouse initiative to provide de-identified patient data for the Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 Registry.

VIRUS Overview

Created by SCCM’s Discovery, the Critical Care Research Network, VIRUS tracks ICU and hospital care patterns in near real-time to enable evaluation of safety and observational effectiveness of COVID-19 practices and to determine practice variations across hospitals. VIRUS is a cross-sectional observational study and registry of eligible adult and pediatric patients admitted to a hospital. There is no intervention or patient interaction and only data, de-identified in accordance with HIPAA, will be used for analysis. The registry features a dashboard which tracks data on trends including length of stay in the ICU and mechanical ventilation duration. The registry will also study mortality and health impact post-ICU.

Lighthouse Initiative Background

VIRUS will partner with Lighthouse, PointClickCare’s newly formed internal group, with a mission to provide healthcare organizations, government agencies and life sciences companies with de-identified data from older adults. The goal of providing data that specifically represents seniors, a population often considered to be at higher risk for severe illness, is to support research by expanding drug discovery and development. Lighthouse will provide the VIRUS COVID-19 Registry with de-identified data on COVID-19 diagnosed patients, including demographics, vitals, medications and health-related outcomes to help better understand their health post-ICU. PointClickCare will continue to deliver relevant data on COVID-19 patients throughout the study period.

“Lighthouse builds on PointClickCare’s commitment to sharing data and insights that drive action for better care, thereby accelerating innovation designed to protect vulnerable populations. We are honored to partner with SCCM and committed to helping shed light on trends in COVID-19 care around the world,” said Mike Wessinger, Founder and Chief Executive Officer, PointClickCare.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The Lighthouse project is just one example of PointClickCare’s efforts to fight COVID-19 and arm frontline workers with the tools they need to keep vulnerable populations safe. Additional innovations include the Infection Prevention and Control (IPC) solution, a clinical workflow and intelligence solution that helps care teams achieve ongoing resident surveillance focused on infection prevention at the facility or enterprise level. PointClickCare has also deployed a Crisis Response and Readiness solution, broadening access to telehealth services for all customers, and enabling a HIPAA-compliant dialogue between staff and physicians.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • R1 Acquires Cerner RevWorks to Extend Revenue Cycle CapabilitiesR1 Acquires Cerner RevWorks to Extend Revenue Cycle Capabilities
  • Dutch Medical AI Company Thirona Launches Software for Cystic FibrosisDutch Medical AI Company Thirona Launches Software for Cystic Fibrosis
  • BD Acquires Venclose, Inc. to Extend Treatment Innovations in Chronic Venous DiseaseBD Acquires Venclose, Inc. to Extend Treatment Innovations in Chronic Venous Disease
  • Siemens Acquires Brightly for $1.57B to Enhance Built InfrastructureSiemens Acquires Brightly for $1.57B to Enhance Built Infrastructure
  • Nymox Pharmaceutical Receives Potential Delisting Notice From NasdaqNymox Pharmaceutical Receives Potential Delisting Notice From Nasdaq
  • Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From NovartisGilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
  • Life Sciences Antitrust Enforcement TrendsLife Sciences Antitrust Enforcement Trends
  • Probo Medical Completes Acquisition of Davis MedicalProbo Medical Completes Acquisition of Davis Medical

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications